Sirnaomics Partners with Bloomage Biotech for Next-Gen Life Science Advancements#Hong_Kong#RNAi_Technology#Sirnaomics#Bloomage_Biotech
Sirnaomics Partners with Bloomage Biotech for Next-Gen Life Science Advancements
Sirnaomics has announced a significant investment from Bloomage Biotech, focusing on enhancing RNAi therapeutic development and commercialization collaborations.
third-news.com
September 8, 2025 at 4:23 AM
Sirnaomics Partners with Bloomage Biotech for Next-Gen Life Science Advancements#Hong_Kong#RNAi_Technology#Sirnaomics#Bloomage_Biotech
The Growing RNAi Technology Market Set to Reach USD 6.63 Billion by 2033#USA#Austin#Alnylam_Pharmaceuticals#RNAi_Technology#Gene_Silencing
The Growing RNAi Technology Market Set to Reach USD 6.63 Billion by 2033
The RNAi technology market is projected to soar from USD 2.75 billion in 2024 to USD 6.63 billion by 2033, driven by innovative therapeutics and strong demand.
third-news.com
September 4, 2025 at 4:41 PM
The Growing RNAi Technology Market Set to Reach USD 6.63 Billion by 2033#USA#Austin#Alnylam_Pharmaceuticals#RNAi_Technology#Gene_Silencing